Socioeconomic status and risk factors for complications in young people with type 1 or type 2 diabetes: a cross-sectional studySasini Wijayaratna, Arier Lee, Hyun Young Park, Emmanuel Jo, Fiona Wu, Warwick Bagg, Tim Cundy
30 December 2021
Application of machine learning techniques to understand ethnic differences and risk factors for incident chronic kidney disease in AsiansCynthia Ciwei Lim, Feng He, Jialiang Li, Yih Chung Tham, Chieh Suai Tan, Ching-Yu Cheng, Tien-Yin Wong, Charumathi Sabanayagam
24 December 2021
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery diseaseLukas Sprenger, Arthur Mader, Barbara Larcher, Maximilian Mächler, Alexander Vonbank, Daniela Zanolin-Purin, Andreas Leiherer, Axel Muendlein, Heinz Drexel, Christoph H Saely
15 November 2021
Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose controlChristophe Kosinski, Jean-Benoît Rossel, Justine Gross, Céline Helbling, Dan Yedu Quansah, Tinh-Hai Collet, Jardena J Puder
8 November 2021
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trialSamuel Dagogo-Jack, Richard E Pratley, David Z I Cherney, Darren K McGuire, Francesco Cosentino, Weichung J Shih, Jie Liu, Robert Frederich, James P Mancuso, Annaswamy Raji, Ira Gantz
7 October 2021
Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America studyM C Sage Ishimwe, Annemarie Wentzel, Elyssa M Shoup, Nana H Osei-Tutu, Thomas Hormenu, Arielle C Patterson, Hadi Bagheri, Christopher W DuBose, Lilian S Mabundo, Joon Ha, Arthur Sherman, Anne E Sumner
16 September 2021
Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studiesShajith Anoop S, Riddhi Dasgupta, Grace Rebekah, Arun Jose, Mercy Prem Inbakumari, Geethanjali Finney, Nihal Thomas
16 September 2021
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trialEmilie H Zobel, Asger Wretlind, Rasmus S Ripa, Viktor Rotbain Curovic, Bernt J von Scholten, Tommi Suvitaival, Tine W Hansen, Andreas Kjær, Cristina Legido-Quigley, Peter Rossing
13 September 2021
Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam StudyFariba Ahmadizar, Kan Wang, Elif Aribas, Lana Fani, Alis Heshmatollah, M Kamran Ikram, Maryam Kavousi
25 August 2021
Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screeningJana J Anderson, Paul Welsh, Frederick K Ho, Lyn D Ferguson, Claire E Welsh, Pierpaolo Pellicori, John G F Cleland, John Forbes, Stamatina Iliodromiti, James Boyle, Robert Lindsay, Carlos Celis-Morales, Stuart Robert Gray, Srinivasa Vittal Katikireddi, Jason Martin Regnald GillSee the full list of authors
5 August 2021